Provided by Tiger Trade Technology Pte. Ltd.

Warrior Met Coal LLC

95.42
-2.3500-2.40%
Volume:134.39K
Turnover:12.79M
Market Cap:5.02B
PE:22.94
High:96.03
Open:96.03
Low:93.89
Close:97.77
52wk High:111.42
52wk Low:57.53
Shares:52.57M
Float Shares:51.78M
Volume Ratio:0.85
T/O Rate:0.26%
Dividend:0.32
Dividend Rate:0.34%
EPS(TTM):4.16
EPS(LYR):1.08
ROE:10.04%
ROA:5.17%
PB:2.19
PE(LYR):88.35

Loading ...

Stock Track | Warrior Met Coal Plummets 7.41% Intraday After UBS Price Target Cut

Stock Track
·
May 01

Stock Track | Warrior Met Coal Plunges 5.31% in Pre-Market After UBS Price Target Cut

Stock Track
·
May 01

UBS Adjusts Price Target on Warrior Met Coal to $102 From $104, Maintains Buy Rating

MT Newswires Live
·
May 01

Analysts’ Opinions Are Mixed on These Materials Stocks: Warrior Met Coal (HCC), Capstone Copper (OtherCSCCF) and Methanex (MEOH)

TIPRANKS
·
May 01

Stock Track | Warrior Met Coal Plunges 5.22% After-Hours on Q1 Earnings and Revenue Miss

Stock Track
·
May 01

Warrior Met Coal Q1 EPS $1.37 Beats $1.16 Estimate, Sales $458.588M Miss $465.987M Estimate

Benzinga Earnings
·
May 01

Warrior Met Coal Inc: Trade Restrictions With China Persist, Global Supply Continues to Pressure Pricing

THOMSON REUTERS
·
May 01

Warrior Met Coal Inc - Reaffirms Full Year 2026 Guidance

THOMSON REUTERS
·
May 01

Warrior Met Coal Q1 EPS USD 1.37

THOMSON REUTERS
·
May 01

Warrior Met Coal price target lowered to $117 from $120 at B. Riley

TIPRANKS
·
Apr 30

Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months

GlobeNewswire
·
Apr 30

Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire
·
Apr 27

HCC Wins Rs 2,917 Crore CIDCO Water Infrastructure Contract in Joint Venture

TIPRANKS
·
Apr 24

Earning Preview: Warrior Met Coal LLC this quarter’s revenue is expected to increase by 67.57%, and institutional views are bullish

Earnings Agent
·
Apr 23

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies

GlobeNewswire
·
Apr 21

Warrior Met Coal Keeps Quarterly Dividend at $0.08 per Share, Payable May 7 to Holders of Record May 1

MT Newswires Live
·
Apr 21

Junshi Biosciences Presents Results from JS207 (PD-1/VEGF BsAb) Phase 2 Combo Studies and JS212 (EGFR/HER3 ADC) FIH Phase 1/2 Study at AACR 2026

GlobeNewswire
·
Apr 21

Warrior Met Coal declares $0.08 quarterly cash dividend

Reuters
·
Apr 21

Sirtex Medical's DOORwaY90 Study Demonstrates 100% Local Tumor Control with SIR-Spheres®, Setting a New Benchmark in Y-90 for HCC

prnewswire
·
Apr 13

Warrior Met Coal (HCC) Valuation Check After Sector Weakness And Analyst Downgrade

Simply Wall St.
·
Apr 13